CRTX - Cortexyme: Positive Lessons To Be Learned From Disappointing Results
- Cortexyme's Alzheimer's drug candidate atuzaginstat appears to help those in the early stages of the disease who have an active P. gingivalis infection.
- Some antibiotics that act as direct antioxidants may slow down cognitive decline in anyone with Alzheimer's disease at any stage.
- Strong scavengers of the nitro-oxidant peroxynitrite have largely stabilized Alzheimer's disease, often over long periods of time.
- Trappsol Cyclo and Anavex 2-73 (blarcamesine) are most likely strong peroxynitrite scavengers and therefore Cyclo Therapeutics and Anavex are best posed to deliver effective treatments for Alzheimer's disease.
For further details see:
Cortexyme: Positive Lessons To Be Learned From Disappointing Results